_PRIVATE_LIMITED.webp)
Bgn Medtex (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
- Revenue Growth -41.41%
- Profit Growth -47.77%
- Ebitda 47.34%
- Net Worth 86.19%
- Total Assets 19.34%
About Bgn Medtex (India)
Bgn Medtex (India) Private Limited (BMIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 01 July 2019 (Five years and seven months 10 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.00 M.
Vipankumar Dewan and Anjana Dewan serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909MH2019PTC327435
-
Company No.
327435
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Jul 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Bgn Medtex (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipankumar Dewan
|
Director | 01-Jul-2019 | Current |
|
Anjana Dewan
|
Director | 01-Jul-2019 | Current |
Financial Performance of Bgn Medtex (India).
Bgn Medtex (India) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.41% decrease. The company also saw a substantial fall in profitability, with a 47.77% decrease in profit. The company's net worth Soared by an impressive increase of 86.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bgn Medtex (India)?
Unlock access to Bgn Medtex (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2023 | Yes Bank Limited | ₹4.00 M | Open |
How Many Employees Work at Bgn Medtex (India)?
Bgn Medtex (India) has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bgn Medtex (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bgn Medtex (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.